NVCT compared with BOLD: revenue, margins and what each company keeps, and the suppliers and customers both name

NVCTNuvectis Pharma, Inc.

Mkt capRevenueRevenue

BOLDBoundless Bio, Inc.

Mkt capRevenueRevenue

Compare

NVCTNuvectis Pharma, Inc.

BOLDBoundless Bio, Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

NVCT

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±38.9%▼−6.94%×0.18

Q1 FY26±56.7%▲+9.22%×0.16

Feb 11 '26±83.7%▲+0.46%×0.01

Nov 4 '25±52.7%▼−7.55%×0.14

BOLD

No earnings history for BOLD.

= impliedNVCT realized, solidBOLD realized, hatchedOne scale, both sides: full bar = 84%× = |realized| ÷ impliedSource: market data

NVCTNuvectis Pharma, Inc.

18.38▼−1.00%· post 18.99

Mkt cap$602.1M

BOLDBoundless Bio, Inc.

2.45▼−1.21%· post 2.45

ClosedOct 30 '26

Mkt cap$56.2M

Compare

ClosedOct 30 '26

NVCTNuvectis Pharma, Inc.

BOLDBoundless Bio, Inc.

18.38▼−1.00%post 18.99

Price

2.45▼−1.21%post 2.45

$602.1M

Mkt cap

$56.2M

NVCT18.38▼−1.00%vsBOLD2.45▼−1.21%ClosedOct 30 '26